India BSE NSE Trading Suspension Orders — February 14, 2026

Trading suspended per BSE notice Feb 14, 2026, due to CIRP, eliminating all liquidity

Suspended Board of Directors replaced by Resolution Professional for Q4 FY2026 results approval, indicating total loss of management control

Unaudited standalone results for quarter ended Dec 31, 2025, taken on record on a Saturday with no metrics disclosed, signaling opacity in financial health

Ongoing CIRP process with no resolution progress or timelines shared across both filings, prolonging uncertainty

Bearish sentiment confirmed in both filings (critical risk level 10/10 materiality), no counterbalancing positive indicators

Lack of suspension duration, exit criteria, or trading restrictions details in either filing, heightening exit barriers for investors

No disclosure of YoY/QoQ trends, financial ratios (e.g., Debt-to-Equity, ROE), or operational metrics, preventing performance benchmarking vs peers

Repeated identical filings on same day amplify governance distress signal without new information, eroding investor confidence

No insider trading activity, pledges, or holdings updates disclosed during CIRP, missing conviction signals

Absence of capital allocation details (dividends, buybacks) amid insolvency, confirming zero shareholder returns priority

Ongoing CIRP with Resolution Professional oversight, suspended board, no progress details

Trading suspension (BSE:517399) with no duration or resumption criteria disclosed in both filings

Board of Directors fully suspended, results approved by RP on unspecified Saturday, indicating control vacuum

No financial metrics, period-over-period comparisons (YoY/QoQ), or ratios shared for Q4 FY2026 results

Suspension tied to insolvency process raises delisting risk, critical materiality 10/10

Identical filings provide zero forward-looking statements, guidance, or transaction details (M&A)

No operational metrics (capacity, volumes, costs) or sentiment beyond bearish, precluding turnaround assessment

BSE notice Feb 14, 2026, flags severe compliance issues without resolution timeline

Potential value unlock if successful bidder emerges post-CIRP, monitor NCLT updates for distressed asset play

Trading suspension creates asymmetry for put options or derivatives if relisted at discount (speculative pre-resumption)

Avoid VXL to rotate into healthy small-cap peers with positive YoY growth, capitalizing on relative strength

Post-resolution acquisition at depressed valuations if CIRP concludes favorably, target 50-70% discounts typical in Indian insolvencies

Track similar suspensions for sector rotation away from distressed instruments makers into stable tech

Q4 FY2026 results opacity may precede full audited disclosure in AGMs; early positioning for surprises

Immediate exit signal for any residual holdings, freeing capital for high-conviction names amid suspensions stream

2/2 filings on VXL Instruments highlight CIRP-driven halts, no financial trends disclosed, implying broader small-cap distress risks

Suspended boards and RP oversight in 100% of filings signal rising NCLT interventions, eroding trust in micro-caps

Zero metrics/period comparisons across both filings prevent trend synthesis, common in suspensions vs operational peers

Trading halts without durations in all cases amplify delisting fears, contrasting liquid large-caps

Absence of dividends/buybacks in insolvency context underscores zero shareholder priority theme

Monitor NCLT filings for resolution plan approvals or bidder shortlists, potential catalyst post-Feb 2026

Track BSE updates on suspension lift criteria or delisting notices following Feb 14, 2026 announcement

Await detailed unaudited standalone metrics for Dec 31, 2025 quarter, may reveal YoY declines

Watch for post-CIRP insider transactions/pledges once board reforms, gauge conviction

Potential scheduled events for RP updates or creditor meetings, check SEBI/BSE calendars Q1 2026

Similar CIRP risks in small-cap instruments sector, scan for clustered halts

Future disclosures may show deteriorating Debt-to-Equity/ROE trends vs pre-CIRP baselines